Biological and Environmental Research Ontology

Last uploaded: December 23, 2022

Id	http://purl.obolibrary.org/obo/NCIT_C77392 http://purl.obolibrary.org/obo/NCIT_C77392
Preferred Name	Enzastaurin
Type	http://www.w3.org/2002/07/owl#Class

prefLabel	Enzastaurin
label	Enzastaurin
Has_Salt_Form	http://purl.obolibrary.org/obo/NCIT_C26658
code	C77392
Has_Target	http://purl.obolibrary.org/obo/NCIT_C17017
prefixIRI	NCIT:C77392
in_subset	http://purl.obolibrary.org/obo/NCIT_C63923 http://purl.obolibrary.org/obo/NCIT_C177537 http://purl.obolibrary.org/obo/NCIT_C116977 http://purl.obolibrary.org/obo/NCIT_C116978 http://purl.obolibrary.org/obo/NCIT_C157711 http://purl.obolibrary.org/obo/NCIT_C157712 See more See less
Display_Name	Enzastaurin
Preferred_Name	Enzastaurin
FDA_UNII_Code	UC96G28EQF
Contributing_Source	CTRP FDA
Chemical_Formula	C32H29N5O2
Maps_To	Enzastaurin
CAS_Registry	170364-57-5
Legacy Concept Name	Enzastaurin
type	http://www.w3.org/2002/07/owl#Class
ALT_DEFINITION	A substance being studied in the treatment of certain types of cancer, including non-Hodgkin lymphoma, breast, colon, lung, ovarian, and prostate. Enzastaurin blocks certain cell signaling pathways, and may prevent the growth of new blood vessels that tumors need to grow. It is a type of serine threonine kinase inhibitor and a type of antiangiogenesis agent.
Is_Value_For_GDC_Property	http://purl.obolibrary.org/obo/NCIT_C1909
subClassOf	http://purl.obolibrary.org/obo/NCIT_C2089
Semantic_Type	Pharmacologic Substance
UMLS_CUI	C1327830

Delete	Subject	Author	Type	Created
No notes to display